help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on February 26, 2004
Molecular Endocrinology, doi:10.1210/me.2003-0247
Molecular Endocrinology Vol. 0, No. 2004 200302471-
doi:10.1210/me.2003-0247
Copyright © 2004 by the Endocrine Society.
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
18/6/1546    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lammi, J.
Right arrow Articles by Aarnisalo, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lammi, J.
Right arrow Articles by Aarnisalo, P.

Submitted on June 24, 2003
Accepted on February 22, 2004

Regulation of the Osteopontin Gene by the Orphan Nuclear Receptor Nurr1 in Osteoblasts

Johanna Lammi, Johanna Huppunen, and Piia Aarnisalo*

Institute of Biomedicine, Biomedicum Helsinki, University of Helsinki, P. O. Box 63, 00014 Helsinki, Finland; Department of Clinical Chemistry, University of Helsinki and Helsinki University Central Hospital, Finland

* To whom correspondence should be addressed. E-mail: piia.aarnisalo{at}helsinki.fi.

The orphan nuclear receptor Nurr1 is mainly expressed in the central nervous system but is also detected in certain peripheral tissues such as bone. To elucidate the role of Nurr1 in bone, we examined the ability of Nurr1 to regulate osteopontin (OPN) expression in osteoblastic cell lines. Transfection of Nurr1 in osteoblastic cells increased OPN mRNA expression. A dominant negative Nurr1 variant abolished the ability of PTH to induce OPN expression suggesting that Nurr1 is involved in mediating the regulation of OPN by PTH. Nurr1 efficiently transactivated a luciferase reporter construct driven by the -857/+191 fragment of the mouse OPN promoter. The activation of the OPN promoter was mediated by the monomeric form of Nurr1, required direct binding of Nurr1 to the OPN promoter, and was dependent on the amino-terminal transactivation function-1. The OPN promoter is also regulated by vitamin D receptor and estrogen-related receptors (ERRs). We show that Nurr1 and vitamin D activate the OPN promoter in a synergistic fashion whereas Nurr1-mediated transactivation of the OPN promoter is repressed by ERRs. In conclusion, Nurr1 activates the OPN promoter directly in osteoblastic cells suggesting a role for Nurr1 in the regulation of bone homeostasis.


Key words: nuclear receptor • Nurr1 • osteopontin • osteoblast

NURSA Molecule Pages Link:

Nuclear Receptors:   VDR  |  ERRα  |  ERRγ  |  NURR1
Ligands:   Calcitriol






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society